[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-356798-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-356798-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","pmepa1-modulates-yap1-nuclear-translocation-to-disrupt-emt-subtypes-and-promote-metastasis-in-biliary-tract-cancer","PMEPA1 modulates YAP1 nuclear translocation to disrupt EMT subtypes and promote metastasis in Biliary tract cancer","","Biliary tract cancer is an aggressive malignancy with limited effective options, where epithelial-mesenchymal transition (EMT) drives metastasis but key regulators remain unclear. Integrative single-cell RNA-seq analysis of 47 BTC samples identifies EMT-enriched epithelial subpopulations and a BTC-specific EMT gene set; higher EMT scores associate with worse prognosis. Multi-omics implicate PMEPA1 as a pivotal EMT regulator via Hippo-YAP1 signaling, specifically YAP1 nuclear localization, and show that SN-38 suppresses EMT-related migration and metastasis in vivo by dampening PMEPA1/FOS transcriptional activity.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/pmepa1-modulates-yap1-nuclear-translocation-to-disrupt-emt-subtypes-and-promote-metastasis-in-biliary-tract-cancer/356798/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/pmepa1-modulates-yap1-nuclear-translocation-to-disrupt-emt-subtypes-and-promote-metastasis-in-biliary-tract-cancer/356798.png","ImageObject",300,407,{"name":42,"@type":43},"Rizky","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What data and analyses support EMT subtype identification in biliary tract cancer?","Question",{"text":63,"@type":64},"The study performs integrative analysis of single-cell RNA sequencing from 47 BTC samples. It identifies EMT-enriched epithelial subpopulations and a BTC-specific EMT gene set used to derive patient classifications via EMT scores.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does PMEPA1 influence EMT progression in this research?",{"text":68,"@type":64},"PMEPA1 knockdown inhibits EMT progression, while PMEPA1 overexpression promotes EMT. The mechanism involves modulation of Hippo-YAP signaling, particularly YAP1 nuclear localization.",{"name":70,"@type":61,"acceptedAnswer":71},"Why is SN-38 investigated, and what is its reported effect in vivo?",{"text":72,"@type":64},"Topoisomerase inhibitor SN-38 is forecast and then validated as a potential EMT-targeting agent. It reduces BTC cell migration and metastasis in vivo, likely by attenuating the transcriptional activity of PMEPA1 and its upstream regulator FOS.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},356798,1790153489,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":127,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},962085564807,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","[www.nature.com/cddis](www.nature.com/cddis)  \nARTICLE OPEN   \nPMEPA1 modulates YAP1 nuclear translocation to disrupt EMT subtypes and promote metastasis in Biliary tract cancer  \nWenwen Xu1,2,3,5, Chaoqun Ma 1,5, Pin Li4, Xinxing Lyu2, Ruitang Xu2, Kaiwen Sheng2, Ting Zhang2, Haoqiang Sun2, ZhaoXiang Zhang2, Ziyi Wang2, Hongguang Li1 ✉, Dianhao Guo 2 ✉ and Shuhong Huang 2 ✉  \n© The Author(s) 2026  \n\n|  | Biliary tract cancer (BTC) is an aggressive tumor with poor prognosis and limited treatment options. Epithelial-mesenchymal transition (EMT) signiﬁcantly contributes to BTC metastasis, yet the critical regulators and underlying molecular mechanisms of EMT remain poorly unclear. In our study, we conducted an integrative analysis of single-cell RNA sequencing (scRNA-seq) data from 47 BTC samples, identifying two EMT-enriched epithelial subpopulations and a BTC speciﬁc EMT gene set. Using the EMT gene set, weclassiﬁed BTC patients and noticed that those with elevated EMT scores had worse prognoses. Additionally, multi-omics analysesidentiﬁed PMEPA1 as a pivotal EMT regulator, with its high expression levels correlating with adverse prognosis and distant metastasis. Functional assays revealed that PMEPA1 knockdown inhibits, while its overexpression promotes EMT progression by modulating Hippo-YAP signaling, speciﬁcally YAP1 nuclear localization. Moreover, we forecast and validated topoisomerase inhibitor SN-38 as a potential EMT-targeting agent. SN-38 effectively inhibited BTC cell migration and metastasis in vivo, likely by attenuating the transcriptional activity of PMEPA1 and its upstream regulator FOS. Overall, this research elucidates EMT-related molecular features in BTC, reveals PMEPA1 as a critical EMT driver via the Hippo-YAP1 pathway, and proposes SN-38 as a promising |  |\n| --- | --- | --- |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n| therapeutic candidate, offering new insights into BTC metastasis and precision therapy. |  |  |\n|  | Cell Death and Disease (2026)17:449; [https://doi.org/10.1038/s41419-026-08684-3](https://doi.org/10.1038/s41419-026-08684-3) |  |\n|  |  |  |\n\nINTRODUCTION  \nBiliary tract cancer (BTC) is an aggressive malignancy that arises from the epithelial cells of the biliary system. Over the past few decades, its incidence has been increasing worldwide, with the highest rates reported in Asian countries [1] . BTC includes several subtypes: intrahepatic cholangiocarcinoma (iCCA), perihilar cholangiocarcinoma (pCCA), distal cholangiocarcinoma (dCCA), and gallbladder cancer (GBC), with most cases classiﬁed as adenocarcinomas [2]. BTC is marked by its aggressiveness, high mortality rate, short survival duration, with a less than 20% 5-year survival rate [3, 4]. Thus, understanding the molecular mechanisms driving BTC invasiveness is essential for identifying novel therapeutic targets, improving treatment effectiveness, and enhancing patient outcomes.  \nEpithelial-mesenchymal transition (EMT) is recognized as a key mechanism driving BTC metastasis [5, 6] . EMT is orchestrated by numerous core EMT transcription factors (TFs), including snail family transcriptional repressors 1/2 (SNAI1/2), twist family bHLH transcription factors 1/2 (TWIST1/2), and zinc ﬁnger E-box binding homeobox factors 1/2 (ZEB1/2) . These TFs promote EMT by suppressing epithelial genes like CDH1 (E-cadherin) and TJP1 (ZO- 1), which reduces cell adhesion. Simultaneously, they induce the expression of mesenchymal genes including VIM (vimentin) and  \nCDH2 (N-cadherin), facilitating cell migration and contributing to cancer cell dissemination and drug resistance [7] . In BTC, EMT is initiated by aberrant epithelial-origin primary cancer lesions, causing a shift from epithelial to mesenchymal phenotypes [8, 9] . Multiple signaling pathways regulate EMT, including TGFB, Wnt, Notch, and Hippo/YAP pathways. The interplay of various signaling pathways and TFs underscores EMT’","cbCaip8xqIShRSvO","https://ap.wps.com/l/cbCaip8xqIShRSvO","pdf",10746786,"English","# Introduction\n## Biliary tract cancer background and clinical challenge\n## EMT as a driver of metastasis\n## EMT heterogeneity and EMT score as a marker\n## Need to identify subtype-specific molecular regulators","[{\"question\":\"What data and analyses support EMT subtype identification in biliary tract cancer?\",\"answer\":\"The study performs integrative analysis of single-cell RNA sequencing from 47 BTC samples. It identifies EMT-enriched epithelial subpopulations and a BTC-specific EMT gene set used to derive patient classifications via EMT scores.\"},{\"question\":\"How does PMEPA1 influence EMT progression in this research?\",\"answer\":\"PMEPA1 knockdown inhibits EMT progression, while PMEPA1 overexpression promotes EMT. The mechanism involves modulation of Hippo-YAP signaling, particularly YAP1 nuclear localization.\"},{\"question\":\"Why is SN-38 investigated, and what is its reported effect in vivo?\",\"answer\":\"Topoisomerase inhibitor SN-38 is forecast and then validated as a potential EMT-targeting agent. It reduces BTC cell migration and metastasis in vivo, likely by attenuating the transcriptional activity of PMEPA1 and its upstream regulator FOS.\"}]","PMEPA1 modulates YAP1 nuclear translocation to disrupt EMT subtypes and promote metastasis in Biliary tract cancer | PDF",1790127339,48,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/603c1a53775ea24b8328bc9a8ced213d.webp",983,1305,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/846992d7b580428627ac7b1ada8a6183.webp",982,1304,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/322f4379110204ed0b2001c8cb4d55d9.webp",981,1303,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/483c298b4fba1b6b93292592af409c5f.webp",980,1301]